CDSCO Certification is the national regulatory clearance required to manufacture, import, or sell medical devices, drugs, or cosmetics in India. It's issued by the Central Drugs Standard Control Organization, under the Ministry of Health & Family Welfare, and it exists as the gatekeeper between a product and the Indian healthcare market — without it, these products simply can't be legally sold here, regardless of approvals held in other countries.

What makes CDSCO different from most other certifications on this site is that the process genuinely depends on what you're registering. A Class A medical device (low risk, like a tongue depressor) goes through a very different process than a Class D device (high risk, like an implant) or a new drug. Getting the classification right at the start is where most of the actual complexity lives.

Which Products Need CDSCO Registration

Three broad categories fall under CDSCO: medical devices (classified A through D by risk level under the Medical Device Rules), drugs and pharmaceuticals (new drugs, generics, and imported formulations), and cosmetics (manufactured or imported for sale in India). Each category has its own licensing pathway, documentation set, and regulatory timeline — a device license application and a drug import license are genuinely different processes, not variations of the same form.

Eligibility — Who Can Apply

Manufacturers with a facility in India, and importers bringing devices, drugs, or cosmetics from overseas, can both apply — though the pathway differs. Indian manufacturers typically apply through the state licensing authority for lower-risk categories and CDSCO centrally for higher-risk ones; importers need an Indian authorised agent and typically route applications centrally through CDSCO regardless of device class, since import licensing sits with the central authority.

CDSCO Registration Process — Step by Step

1. Determine the correct classification

We confirm whether your product is a drug, a medical device (and which risk class, A to D), or a cosmetic — this single decision determines almost everything else about the application.

2. Identify the licensing authority

Depending on classification and risk class, the application goes to either the state licensing authority or CDSCO centrally — getting this wrong means re-filing.

3. Prepare technical and regulatory documentation

This includes the Device Master File or Plant Master File for devices, or equivalent drug/cosmetic documentation, covering manufacturing process, quality systems, and safety data.

4. Compile clinical or safety evidence where required

Higher-risk devices and new drugs typically need clinical trial data or safety study evidence; lower-risk products may only need existing test reports and quality certifications.

5. Submit through the SUGAM online portal

CDSCO applications are filed through the SUGAM portal, along with supporting documents and the prescribed fee.

6. Respond to CDSCO queries

It's common to get clarification requests during review — missing documentation, a question on manufacturing process, or a request for additional test data — and timely responses matter for keeping the timeline on track.

7. Licence or registration grant

Once CDSCO is satisfied, the manufacturing licence, import licence, or registration certificate is issued for that specific product.

8. Post-approval compliance

Ongoing pharmacovigilance or adverse-event reporting obligations (for drugs and higher-risk devices) continue after approval — CDSCO clearance isn't a one-time event for these categories.

Documents Required

• Device Master File (DMF) or Plant Master File (PMF) for medical devices.
• Clinical trial data (Phase I, II, III), where applicable to the product's risk class.
• Free Sale Certificate, relevant for export and sometimes required to support import applications.
• Manufacturing or wholesale licence issued by the state authority.
• Certificate of Pharmaceutical Product (COPP) for exports.
• ISO or GMP certification demonstrating quality management compliance.
• Label artwork, ingredient lists, and usage instructions.
• Ethics Committee approval, for clinical studies involving human participants.

Why Classification Is the Hardest Part

Most delays we see trace back to classification, not paperwork. The same general type of product can fall into different risk classes depending on its intended use, invasiveness, or duration of body contact — a Class B device misclassified as Class A means the application was built on the wrong evidentiary standard and needs rework once CDSCO flags it. Getting an experienced read on classification before documentation starts saves far more time than it costs.

How Long Does CDSCO Approval Take?

This varies more than almost any other certification on this site, because it's genuinely risk-tiered by design. Lower-risk (Class A/B) medical device registrations can take 3 to 6 months; higher-risk (Class C/D) devices and new drug approvals, especially those requiring clinical data, can take 9 to 18 months or longer. Cosmetics registration is typically faster, often 2 to 4 months. We give a realistic estimate once classification is confirmed, since quoting one number across such different pathways would be misleading.

Cost Factors

Cost is driven by the licensing category and risk class (government fees scale with device class and licence type), the volume and complexity of clinical or safety data required, and consulting/documentation support needed to prepare a Device or Plant Master File from scratch if one doesn't already exist. Import licences also carry different fee structures than domestic manufacturing licences.

Common Mistakes That Cause Delays

The patterns we see most: misclassifying a device's risk category, which forces a rebuild of the application once caught; assuming a Free Sale Certificate from another country substitutes for Indian regulatory evidence (it doesn't, on its own); underestimating how long clinical evidence compilation takes for higher-risk products; and treating CDSCO approval as a finish line rather than the start of ongoing compliance obligations like adverse-event reporting.

Benefits of CDSCO Registration

Beyond legal market access, a valid CDSCO registration is what institutional buyers — hospitals, government procurement, distributors — check for before they'll even evaluate a product, since it's their own regulatory exposure on the line too. It also meaningfully speeds up customs clearance on every shipment for imported products, and it reduces the risk of a costly product recall or market withdrawal later, which is a far more expensive problem than getting classification right at the outset.